Riskpilot← Back to searchSign inGet full accessQ-BIO AS
ASActiveOrg 923640770Schultz' gate 6, 0365 OsloEngineering activities and related technical consultancy · NACE 7112Est. 20190 employees
Revenue 2024
NOK 0
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2024
NOK 0
0 employees
| Revenue | NOK 0 | — |
| EBITDA | NOK 0 | — |
| Net profit | NOK 0 | — |
| Total assets | NOK 0 | — |
| Equity | NOK -48K | +0% |
| Employees | 0 | — |
Legal name
Q-BIO AS
Org number
923640770
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
21. oktober 2019
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Tjenester knyttet til miljøbaserte nedstrømsløsninger for gjenvinning til bioenergi og det som står i forbindelse med dette, herunder å delta i andre selskaper med slikt formål.
Address
Schultz' gate 6, 0365 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 8 | 0 | 0 | 0 |
| Staff expenses | −5 | −29 | −0 | −0 | −0 |
| EBITDA | −12 | −44 | −1 | 0 | 0 |
| Depreciation & amort. | −7 | −7 | −0 | −0 | −0 |
| EBIT | −19 | −51 | −1 | 0 | 0 |
| Net financials | 0 | −0 | 0 | 0 | 0 |
| Profit before tax | −19 | −51 | −1 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −19 | −51 | −1 | 0 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 16 | 0 | 0 | 0 | 0 |
| Equity | 5 | −47 | −48 | −48 | −48 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 11 | 47 | 48 | 48 | 48 |
| Total debt | 11 | 47 | 48 | 48 | 48 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
-4766300.0%
This company
38.2%
Market median
-12477325% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2019 | |
| Board of Directors | 2019 | |
| Chairman | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Q-BIO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Asbjørn Ulven Nordahl-Lundberg | Chairman | 0 companies |
| Anna Nordahl | Board of Directors | 0 companies |
| Asbjørn Ulven Lundberg | Chairman | 0 companies |